Evidence map›Paper›PMID 35869353›Full record

ArticleInfection2023

Post-COVID-19 condition is not only a question of persistent symptoms: structured screening including health-related quality of life reveals two separate clusters of post-COVID.

Benjamin Giszas, Sabine Trommer, Nane Schüßler, Andrea Rodewald, Bianca Besteher, Jutta Bleidorn, Petra Dickmann, Kathrin Finke, Katrin Katzer, Katja Lehmann-Pohl and 7 more

Abstract read
In one paragraph

Article in Infection, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Illness presentation and quality of life in myalgic encephalomyelitis/chronic fatigue syndrome and post COVID-19 condition: a pilot Australian cross-sectional study.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. [Outpatient Long/Post-COVID Care: Barriers and Desires of Affected Persons to Medical Care].Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)) · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Benjamin GiszasDepartment of Internal Medicine IV (Gastroenterology, Hepatology and Infectious Diseases), Jena University Hospital/Friedrich-Schiller-University Jena, Am Klinikum 1, 07747, Jena, Germany. benjamin.giszas@med.uni-jena.de.ORCID http://orcid.org/0000-0003-3596-1437
Sabine TrommerPublic Health Department, City of Jena, 07743, Jena, Germany.
Nane SchüßlerDepartment of Internal Medicine IV (Gastroenterology, Hepatology and Infectious Diseases), Jena University Hospital/Friedrich-Schiller-University Jena, Am Klinikum 1, 07747, Jena, Germany.
Andrea RodewaldDepartment of Internal Medicine IV (Gastroenterology, Hepatology and Infectious Diseases), Jena University Hospital/Friedrich-Schiller-University Jena, Am Klinikum 1, 07747, Jena, Germany.
Bianca BesteherDepartment of Psychiatry, Jena University Hospital/Friedrich-Schiller-University Jena, Jena, Germany.
Jutta BleidornDepartment of General Practice, University Hospital Jena, Jena, Germany.
Petra DickmannCenter for Sepsis Control and Care (CSCC), Jena University Hospital/Friedrich-Schiller-University Jena, Jena, Germany.
Kathrin FinkeCenter for Sepsis Control and Care (CSCC), Jena University Hospital/Friedrich-Schiller-University Jena, Jena, Germany.
Katrin KatzerDepartment of Internal Medicine IV (Gastroenterology, Hepatology and Infectious Diseases), Jena University Hospital/Friedrich-Schiller-University Jena, Am Klinikum 1, 07747, Jena, Germany.ORCID http://orcid.org/0000-0003-1136-0784
Katja Lehmann-PohlCenter for Sepsis Control and Care (CSCC), Jena University Hospital/Friedrich-Schiller-University Jena, Jena, Germany.
Christina LemhöferInstitute of Physiotherapy, Jena University Hospital, Jena, Germany.ORCID http://orcid.org/0000-0002-6206-4064
Mathias W PletzCenter for Sepsis Control and Care (CSCC), Jena University Hospital/Friedrich-Schiller-University Jena, Jena, Germany.ORCID http://orcid.org/0000-0001-8157-2753
Christian PutaDepartment of Sports Medicine and Health Promotion, Friedrich-Schiller-University Jena, Jena, Germany.
Stefanie QuickertDepartment of Internal Medicine IV (Gastroenterology, Hepatology and Infectious Diseases), Jena University Hospital/Friedrich-Schiller-University Jena, Am Klinikum 1, 07747, Jena, Germany.
Martin WalterDepartment of Psychiatry, Jena University Hospital/Friedrich-Schiller-University Jena, Jena, Germany.
Andreas StallmachDepartment of Internal Medicine IV (Gastroenterology, Hepatology and Infectious Diseases), Jena University Hospital/Friedrich-Schiller-University Jena, Am Klinikum 1, 07747, Jena, Germany.ORCID http://orcid.org/0000-0002-6101-5244
Philipp Alexander ReukenDepartment of Internal Medicine IV (Gastroenterology, Hepatology and Infectious Diseases), Jena University Hospital/Friedrich-Schiller-University Jena, Am Klinikum 1, 07747, Jena, Germany.ORCID http://orcid.org/0000-0002-7696-475X

Funding

Interdisciplinary Centre for Clinical Research (IZKF) Jena IZKF-CSPOA19Thüringer Aufbaubank 2021FGI0060
6 · The paper itself

Abstract

purposeSome patients experience long-term sequelae after infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, despite a present post-COVID condition, defined as "any symptom lasting longer than 12 weeks," only a subset of patients search for medical help and therapy.

methodWe invited all adults with a positive real-time polymerase chain reaction (RT-PCR) for SARS-CoV-2 between March 2020 and September 2021 (n = 4091) in the city of Jena to answer a standardized questionnaire including demographic information, the course of the acute infection and current health status. K-means-clustering of quality of life (QoL) was used to explore post-COVID subgroups.

resultsA total of 909 participants at a median interval of 367 (IQR 291/403) days after acute infection were included in the analysis. Of those, 643 (70.7%) complained of having experienced persistent symptoms at the time of the survey. Cluster analysis based on QoL revealed two subgroups of people with persistent post-COVID symptoms. Whereas 189/643 participants (29.4%) showed markedly diminished QoL, normal QoL was detected in 454/643 individuals (70.6%).

conclusionDespite persistent symptoms being reported by nearly three quarters of participants, only one-third of these described a significant reduction in QoL (cluster 1), whereas the other two-thirds reported a near-normal QoL (cluster 2), thus indicating a differentiation between "post-COVID disease" and "post-COVID condition". The prevalence of clinically relevant post-COVID disease was at least 20.7%. Health policies should focus on this subset.

Indexed as

COVID-19SARS-CoV-2AdultHumansPost-Acute COVID-19 SyndromeQuality of LifeReal-Time Polymerase Chain ReactionCluster analysisDifferentiationPost-COVID-19Post-COVID conditionPrevalenceQoL

Identifiers

PMID35869353
PMCPMC9307219

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.